PT86292A - Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril) - Google Patents

Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril)

Info

Publication number
PT86292A
PT86292A PT86292A PT8629287A PT86292A PT 86292 A PT86292 A PT 86292A PT 86292 A PT86292 A PT 86292A PT 8629287 A PT8629287 A PT 8629287A PT 86292 A PT86292 A PT 86292A
Authority
PT
Portugal
Prior art keywords
potassium channel
cromacaline
enalapril
preparation
ace inhibitor
Prior art date
Application number
PT86292A
Other languages
English (en)
Other versions
PT86292B (pt
Inventor
Robin Edwin Buckingham
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629234A external-priority patent/GB8629234D0/en
Priority claimed from GB868630926A external-priority patent/GB8630926D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT86292A publication Critical patent/PT86292A/pt
Publication of PT86292B publication Critical patent/PT86292B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT86292A 1986-12-06 1987-12-04 Processo para a preparacao de uma composicao farmaceutica anti-hipertensora, contendo um activador de canal de potassio (por exemplo, cromacalina) e um inibidor de ace (por exemplo, enalapril) PT86292B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629234A GB8629234D0 (en) 1986-12-06 1986-12-06 Pharmaceutical preparations
GB868630926A GB8630926D0 (en) 1986-12-24 1986-12-24 Pharmaceutical preparations

Publications (2)

Publication Number Publication Date
PT86292A true PT86292A (pt) 1988-01-01
PT86292B PT86292B (pt) 1990-11-07

Family

ID=26291661

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86292A PT86292B (pt) 1986-12-06 1987-12-04 Processo para a preparacao de uma composicao farmaceutica anti-hipertensora, contendo um activador de canal de potassio (por exemplo, cromacalina) e um inibidor de ace (por exemplo, enalapril)

Country Status (11)

Country Link
EP (1) EP0271271B1 (pt)
KR (1) KR880007081A (pt)
AT (1) ATE71535T1 (pt)
AU (1) AU607728B2 (pt)
CA (1) CA1305420C (pt)
DE (1) DE3776111D1 (pt)
DK (1) DK639887A (pt)
ES (1) ES2055709T3 (pt)
GR (1) GR3003599T3 (pt)
NZ (1) NZ222806A (pt)
PT (1) PT86292B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
GB8915315D0 (en) * 1989-07-04 1989-08-23 Sandoz Ltd Pharmaceutical compositions for use against hypertension and congestive heart failure
EP0555681A1 (en) * 1992-02-13 1993-08-18 E.R. SQUIBB & SONS, INC. Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct
EP0673374B1 (en) * 1992-12-11 2000-03-01 Smithkline Beecham Plc Pharmaceutical composition containing bicyclic type compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
ATE71535T1 (de) 1992-02-15
GR3003599T3 (pt) 1993-03-16
DK639887A (da) 1988-06-07
KR880007081A (ko) 1988-08-26
CA1305420C (en) 1992-07-21
EP0271271B1 (en) 1992-01-15
DE3776111D1 (de) 1992-02-27
EP0271271A3 (en) 1989-11-15
PT86292B (pt) 1990-11-07
AU607728B2 (en) 1991-03-14
NZ222806A (en) 1991-05-28
ES2055709T3 (es) 1994-09-01
DK639887D0 (da) 1987-12-04
AU8209987A (en) 1988-06-09
EP0271271A2 (en) 1988-06-15

Similar Documents

Publication Publication Date Title
ES2042776T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
DE69726577D1 (en) Kristallin form i von clarithromycin
TR200002869T2 (tr) İkame edilmiş indolealkonik asitler.
DE93619T1 (de) Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer.
BR9812339A (pt) Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente
PT83872A (de) Arzneimittel
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
PT86292A (pt) Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril)
IT1227072B (it) Clavulanato di potassio, procedimento per la sua produzione e composizione farmaceutica
PT90661A (pt) Processo para a preparacao de composicoes farmaceuticas contendo inibidores da enzima conversora de angiotensina e moduladores de canal de potassio
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IT8848327A0 (it) Composizione orale solida per la cura o profilassi di mancanza di potassio e magnesio e metodo per applicarla
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
AU642961B2 (en) Pharmaceutical composition
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ATE46360T1 (de) Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940930